NCT05150912

Brief Summary

2 groups of patients randomized for the treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
412

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 26, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 24, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 15, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

December 9, 2021

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2023

Completed
Last Updated

July 19, 2023

Status Verified

July 1, 2023

Enrollment Period

1.6 years

First QC Date

November 15, 2021

Last Update Submit

July 18, 2023

Conditions

Carpal Tunnel Syndrome

Outcome Measures

Primary Outcomes (2)

  • PAIN and function

    Boston carpal tunnel questionnaire (BCTQ) measure function and pain

    after one year

  • muscle strength

    measured by dynamometer to measure cylindrical grip and pincer grip

    3 month

Study Arms (2)

Neuro dynamic

ACTIVE COMPARATOR

Neurodynamic techniques.

Other: Manual therapy

desensitization

ACTIVE COMPARATOR

Desensitization maneuvers

Other: Manual therapy

Interventions

Manual therapyOTHER

strching neck

Neuro dynamicdesensitization

Eligibility Criteria

Age45 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pain and paresthesia at median nerve distribution ,positive tinel sign and positive phalen sign.

You may not qualify if:

  • Any sensory and/or motor deficit in either ulnar or radial nerve
  • age greater than 55 years .
  • male sex.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahar

Cairo, 11431, Egypt

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Interventions

Musculoskeletal Manipulations

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

November 15, 2021

First Posted

December 9, 2021

Study Start

February 26, 2020

Primary Completion

September 24, 2021

Study Completion

May 24, 2023

Last Updated

July 19, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)